Sign in

CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
263407249
Phone
(302) 295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-01-03 Werner Milton H. President and CEO Option exercise · Stock Option (right to buy) −21,853 0
2021-11-17 Werner Milton H. President and CEO Purchase +17,569 $1.98 $35K 23,589
2021-11-17 Werner Milton H. President and CEO Purchase +1,100 $1.97 $2K 23,589
2021-11-17 Werner Milton H. President and CEO Purchase +3,186 $1.96 $6K 23,589
2021-11-17 Werner Milton H. President and CEO Purchase +1,334 $1.94 $3K 23,589
2021-11-17 Werner Milton H. President and CEO Purchase +400 $1.93 $772 23,589
2021-08-17 Werner Milton H. President and CEO Option exercise +21,853 $2.02 $44K 5,293,580
2021-08-17 Werner Milton H. President and CEO Option exercise · Stock Option (right to buy) −21,853 0
2021-06-25 O'Farrell Elizabeth G. Director Grant or award · Stock Option (right to buy) +22,677 22,677
2021-06-25 GRINT PAUL C Director Grant or award · Stock Option (right to buy) +22,677 22,677
2021-06-25 Freeman Roy Lester Director Grant or award · Stock Option (right to buy) +22,677 22,677
2021-06-25 BERMAN DENNIS N Director Grant or award · Stock Option (right to buy) +22,677 22,677
2021-05-14 Werner Milton H. President and CEO Option exercise +43,707 $0.38 $17K 5,288,645
2021-05-14 Werner Milton H. President and CEO Shares withheld for taxes −16,918 $4.59 $78K 5,271,727
2021-05-14 Werner Milton H. President and CEO Option exercise · Stock Option (right to buy) −43,707 0
2020-12-28 FRATTAROLI JOSEPH Chief Financial Officer Conversion +44,143 $10.00 $441K 44,143
2020-12-28 FRATTAROLI JOSEPH Chief Financial Officer Conversion · Convertible Note −0 0
2020-12-22 BERMAN DENNIS N Director Grant or award · Stock Option (right to buy) +6,825 6,825
2020-12-22 O'Farrell Elizabeth G. Director Grant or award · Stock Option (right to buy) +6,825 6,825
2020-12-22 GRINT PAUL C Director Grant or award · Stock Option (right to buy) +6,825 6,825

Page 8 of 9 · 163 trades